IRIS
GALLO, Ciro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.901
EU - Europa 4.541
AS - Asia 863
AF - Africa 7
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 10.328
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.888
IE - Irlanda 1.458
UA - Ucraina 875
GB - Regno Unito 601
DE - Germania 547
CN - Cina 371
IT - Italia 333
SG - Singapore 294
SE - Svezia 238
FI - Finlandia 219
GR - Grecia 140
TR - Turchia 138
FR - Francia 46
BE - Belgio 20
AT - Austria 16
IR - Iran 13
KR - Corea 12
CA - Canada 10
IN - India 10
CZ - Repubblica Ceca 7
ES - Italia 7
TH - Thailandia 7
TW - Taiwan 7
CH - Svizzera 6
EU - Europa 5
NL - Olanda 5
RO - Romania 5
BG - Bulgaria 4
HK - Hong Kong 4
PH - Filippine 4
AU - Australia 3
BR - Brasile 3
MA - Marocco 3
RS - Serbia 3
BF - Burkina Faso 2
EG - Egitto 2
HU - Ungheria 2
MX - Messico 2
NZ - Nuova Zelanda 2
PL - Polonia 2
PT - Portogallo 2
RU - Federazione Russa 2
AR - Argentina 1
CO - Colombia 1
CR - Costa Rica 1
EC - Ecuador 1
ID - Indonesia 1
JP - Giappone 1
MT - Malta 1
NO - Norvegia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 10.328
Salva come PNG Salva come JPEG
Città #
Dublin 1.457
Jacksonville 1.276
Chandler 859
Santa Clara 370
Princeton 235
Bremen 221
Medford 208
Singapore 164
Boardman 153
San Mateo 135
Ann Arbor 124
Wilmington 120
Roxbury 117
Beijing 102
Ashburn 95
Woodbridge 85
Caserta 53
Jinan 48
Des Moines 46
Mountain View 41
Cambridge 39
Nanjing 34
Houston 25
Zhengzhou 20
Brussels 19
Norwalk 19
New York 18
Düsseldorf 17
Napoli 16
Vienna 16
Nanchang 15
Ningbo 14
Munich 12
Campodarsego 11
Helsinki 11
Los Angeles 11
Naples 11
Scottsdale 11
Shenyang 11
Dearborn 10
Haikou 10
Seoul 10
Changsha 9
Kunming 9
Padova 9
Venice 9
Redwood City 8
Guangzhou 7
Hangzhou 7
Taiyuan 7
Tianjin 7
Brno 6
Hebei 6
Lanzhou 6
Ponte San Pietro 6
Rome 6
Taizhou 6
Auburn Hills 5
Bari 5
Bologna 5
Fairfield 5
Sant'antimo 5
Cantù 4
Hong Kong 4
Istanbul 4
London 4
Orange 4
Seattle 4
Zanjan 4
Abbiategrasso 3
Agadir 3
Aversa 3
Bangkok 3
Calgary 3
Cattolica 3
Constanța 3
Guido 3
Jiaxing 3
Lipa City 3
Milan 3
Namakkal 3
Philadelphia 3
San Rafael 3
Serravalle Pistoiese 3
Sofia 3
Tappahannock 3
Acerra 2
Aci Catena 2
Andover 2
Bakırköy 2
Bergamo 2
Burnips 2
Caltanissetta 2
Castelnuovo Rangone 2
Catanzaro 2
Changchun 2
Chiang Mai 2
Chon Buri 2
Falls Church 2
Frankfurt am Main 2
Totale 6.509
Salva come PNG Salva come JPEG
Nome #
A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients 183
Association between thraetened pre-term labour and periodontal disease: does a relationship exist? A matched case-control study 105
Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial 93
Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial 90
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): A randomised, multicentre, open-label, phase 3 trial 79
Symptomatic Toxicities Experienced During Anticancer Treatment: Agreement Between Patient and Physician Reporting in Three Randomized Trials 78
null 73
Weekly docetaxel versus CMF as adjuvant chemotherapy for older women with early breast cancer: final results of the randomized phase III ELDA trial 71
Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer 70
Epidemiology of chronic kidney disease in Italy: the CARHES study 68
Cisplatin in addition to single-agent first-line chemotherapy in elderly patients with advanced non-small-cell lung cancer (NSCLC): efficacy results of a joint analysis of the multicentre, randomized phase 3 MILES-3 and MILES-4 studies 67
First-Line Erlotinib Followed by Second-Line Cisplatin- Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial 65
Epidemiological study on behavioural and emotional problems in developmental age: prevalence in a sample of Italian children, based on parent and teacher reports. 65
Efficacia e sicurezza della combinazione colistina-rifampicina in confronto con la colistina in monoterapia nelle infezioni gravi da Acinetobacter baumannii MDR: risultati preliminari 64
An international, multicenter, randomized phase III study of first-line erlotinib followed by second-line cisplatin/gemcitabine versus first-line cisplatin/gemcitabine followed by second-line erlotinib in advanced non-small-cell lung cancer: treatment rationale and protocol dynamics of the TORCH trial 63
Chronic active hepatitis in Italy: a multicentric study on clinical and laboratory data of 1151 cases. A report from the study group for CAH of the Italiana Association for the Study of the Liver 63
Survival after locoregional treatments for hepatocellular carcinoma: a cohort study in real-world patients. 63
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma. A Cancer of the Liver Italian Program (CLIP 08)retrospective case-control study 62
Management of hypertension in chronic kidney disease: the Italian multicenter study. 61
Characteristics at presentation and outcome of hepatocellular carcinoma (HCC) in the elderly. A study of the Cancer of the Liver Italian Program (CLIP) 61
Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study 60
Dental occlusion and body posture in growing subjects. A population-based study in 12-year- old Italian adolescents 60
Rationale and Design of MILES-3 and MILES-4 Studies: Two Randomized Phase 3 Trials Comparing Single-Agent Chemotherapy Versus Cisplatin-Based Doublets in Elderly Patients With Advanced Non-Small-Cell Lung Cancer 59
Differenti modalità di classificazione e significato prognostico delle aritmie ventricolari dopo infarto acuto del miocardio 59
Consumi, abitudine e atteggiamentei verso alcool, tabacco e caffé. Indagine campionaria in una USL napoletana 59
Health effects associated with the disposal of solid waste in landfills and incinerators in populations living in surrounding areas: a systematic review 59
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial 58
Prognostic significance of circulating immune complexes in a long-term follow-up of breast cancer patients 58
Cetuximab and gemcitabine in elderly or adult PS2 patients with advanced non-small-cell lung cancer: The cetuximab in advanced lung cancer (CALC1-E and CALC1-PS2) randomized phase II trials 58
Management of hypertension in chronic kidney disease: the italian multicentric study 57
Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 study. 57
Is epirubicin effective in first-line chemotherapy of metastatic breast cancer (MBC) after an epirubicin-containing adjuvant treatment? A single centre phase III trial 57
A randomised clinical trial of two docetaxel regimens (weekly vs 3 week) in the second-line treatment of non-small-cell lung cancer. The DISTAL 01 study 56
Application of a statistical approach to determining reference intervals in clinical chemistry 56
Carboplatin plus vinorelbine plus G-CSF in elderly patients with extensive-stage small-cell lung cancer: a poorly tolerated regimen. Results of a multicentre phase II study 56
La richiesta del consenso nelle sperimentazioni cliniche controllate 56
Atti del Convegno della Società Italiana di Statistica Medica ed Epidemiologia Clinica 56
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 56
Early PET/CT Scan Is More Effective Than RECIST in Predicting Outcome of Patients with Liver Metastases from Colorectal Cancer Treated with Preoperative Chemotherapy Plus Bevacizumab 56
Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy 55
Is human hepatocellular carcinoma a hormone-responsive tumor? 55
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials 55
Morbidity patterns in aged population in southern Italy. A survey sampling 54
Modulation of 5-fluorouracil as adjuvant systemic chemotherapy in colorectal cancer: the IGCS-COL multicentre, randomised, phase III study 54
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial. 54
Informed versus randomised consent to clinical trials 54
The role of surgery in transmitting "post-transfusion" hepatitis 54
Fattori di rischio per l'infezione tifoidea nell'area geografica del golfo di Napoli 54
A multivariate strategy for the statistical treatment of chemico-clinical data and the construction of reference regions 54
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC 54
A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme) 54
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer. 53
Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: Safety data from the multicentre phase 3 randomised ELDA trial 53
Adjuvant chemoendocrine therapy for early breast cancer: is it worthwhile? 53
CMF vs alternating CMF/EV in the adjuvant treatment of operable breast cancer. A single centre randomised clinical trial (Naples GUN-3 study) 53
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 53
Analisi dei potenziali fattori di distorsione ('bias') operanti nello studio della storia naturale della epatite cronica persistente da HBV 53
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy. 53
A multicenter, randomized, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in extensive small-cell lung cancer (SCLC) patients: The Small-cell-lung cancer Toxicity Adjusted Dosing (STAD-1) trial 53
Immunosuppressive therapy of HBsAg-positive chronic active hepatitis in childhood: a multicentric restrospective study on 139 patients 52
Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter survey 52
Il rischio di complicanze nel paziente operato: problemi metodologici 52
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group 52
Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials 52
Reply to V. Lorusso et al. 51
Individual patient data meta-analysis of docetaxel administered once every 3 weeks compared with once every week second-line treatment of advanced non-small-cell lung cancer 51
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy: a multicenter European study 51
Survey of modalities of toxicity assessment and reporting in noncomparative prospective studies of chemotherapy in breast cancer 51
Comparison of predictive accuracy of four prognostic models fr non-metastatic renal cell carcinoma after nephrectomy. A multicentre European study 51
Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer: the randomized phase 3 HOBOE study 51
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials 51
Clinical and histological aspects of chronic HCV infection and cirrhosis 50
Chemotherapy-induced neutropenia: a useful predictor of treatment efficacy? 50
Hormonal treatment of human hepatocellular carcinoma 50
Valutazione prognostica dei pazienti sopravvissuti ad infarto acuto del miocardio: analisi uni- e multivariata 50
A prognostic index for patients within the intermediate stage of hepatocellular carcinoma 50
Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group 49
Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data 49
Time spent for activation of non-profit studies in oncology in Italy 49
La determinazione della statura attraverso la lunghezza radiografica del radio e dell'ulna 49
Definizione di un indice prognostico multifattoriale della mortalità postoperatoria 49
Comparaison de la précision predictive de quatre modèles pronostiques dans le cancer du rein localisé 49
Confronto dell’accuratezza predittiva di quattro modeli prognostici per il carcinoma renale non metastatico. Uno studio multicentrico europeo 49
Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-alpha in advanced malignant melanoma 49
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 49
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial 48
Phase I study of carboplatin, cisplatin and cyclophosphamide without and with lenogastrim for the treatment of ovarian cancer 48
Tamoxifen in the treatmnent of hepatocellular carcinoma: 5 years results of the CLIP-1 multicentre randomised controlled trial 48
Twenty-year results of the Naples GUN randomized trial: predictive factors of adjuvant tamoxifen efficacy in early breast cancer 48
Valutazione ed interpretazione di un indice prognostico multifattoriale di rischio chirurgico 48
Studio epidemiologico sul consumo di alcool, tabacco e caffé in una ISL napoletana 48
Etiological, clinical and laboratory data of post-transfusion hepatitis: a retrospective study of 379 cases from 53 Italian hospitals 48
Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non-Small-Cell Lung Cancer 48
BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer. 48
Il gioco dell'oca 48
A phase 2, open label, multicenter, single arm study of tocilizumab on the efficacy and tolerability of tocilizumab in the treatment of patients with COVID-19 pneumonia (TOCIVID-19 trial): Statistical analysis plan 48
Prevalence of varicose veins in an Italian elderly population 47
A predictive index of axillary nodal involvement in operable breast cancer 47
Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer 47
Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression 47
Totale 5.736
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.996
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.996
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020754 0 0 0 0 210 25 238 48 121 44 56 12
2020/20211.858 186 10 212 94 379 25 237 202 19 257 189 48
2021/20221.315 144 4 3 21 482 5 24 38 46 65 102 381
2022/20233.048 262 55 31 297 435 264 4 178 1.389 17 49 67
2023/20241.044 105 38 102 101 385 30 18 14 3 20 64 164
2024/2025551 12 29 32 55 423 0 0 0 0 0 0 0
Totale 10.543